Parkinson’s Institute and Clinical Center is pleased to announce the appointment of Dr. Anthony Santiago as its new Chief Medical Officer. Dr. Santiago is among the nation’s top neurologists and Movement Disorders Specialists, and he is a dynamic leader who will grow our world-class multidisciplinary clinic.

Dr. Santiago has spent his career focused on making a meaningful impact for people affected by Parkinson’s. He will join our doctors in the clinic and begin seeing patients shortly. Additionally, Dr. Santiago is already recruiting the nation’s top Movement Disorder Specialists to join the team at the Parkinson’s Institute and Clinical Center.

Dr. Santiago most recently served as the Chief Medical Officer and a member of the Board of Directors, for Pathways Group, Inc., a professional consortium of clinicians, data scientists, educators, academic and industry translational researchers, professional athletes, and community leaders dedicated to improving the lives of people with neurodegenerative disorders. Dr. Santiago was responsible for the development, validation, and integration of medical content for its telehealth platform, designed to solve the challenges inherent to providing a virtual portal for sophisticated specialized patient care and clinical trial performance. He served as the liaison to academic, biomedical industry, healthcare systems, and commercial payers for strategic partnerships; led recruitment, supervision, and mentoring of medical directors; and provided oversight and coordination of multi-disciplinary, nationally-based operational teams responsible for telehealth platform development.

Prior to Pathways Group, Inc., Dr. Santiago was Associate Professor and Vice-Chair of the Department of Neurology at the University of Minnesota (UMN) School of Medicine, where he also served as the Chief of the Divisions of Movement Disorders and Ataxia; Director of the Neurology Residency Program; Director of the Movement Disorders / Neuromodulation Fellowship Program; and Core Administrative Director for the Udall Parkinson’s Disease Center of Excellence at the UMN – a National Institute of Health funded, highly-competitive, and prestigious initiative for which only eight institutes are designated in the US.

Prior to his arrival at the UMN, he was Associate Professor of Neurology and National Parkinson Foundation Center Director at the Muhammad Ali Parkinson Center of the Barrow Neurological Institute – a designated National Center of Excellence in care delivery, education, research, and patient outreach. He also served as the Director for Clinical and Translational Research in Neurodegenerative Disorders, and as the Director of the Movement Disorders/Neuromodulation Fellowship Program.

Dr. Santiago is an Alpha Omega Alpha graduate of the Albany Medical College in Albany, NY – one of the oldest and most prestigious private medical schools in the US – where he also completed his post‐graduate training in Neurology, a Fellowship in Movement Disorders/Neuromodulation, and was an Assistant Professor in the Neurology Department.

Dr. Santiago is a nationally-recognized expert in neurodegenerative disorders. He is a highly-active investigator for both industry-sponsored and publicly-funded research; author of numerous peer‐reviewed journal articles and book chapters; frequent lecturer for patient advocacy groups (the Davis Phinney Foundation, the Parkinson Foundation, the American Parkinson Disease Association, the Michael J Fox Foundation), industry partners in pharmacological and medical-device development, academic institutions and professional medical societies. He is a nationally‐awarded educator recognized for his outstanding didactic and clinical teaching; his trainees have gone on to the some of the most coveted fellowship and faculty positions in Neurology in the US. He is a consummate diagnostician and clinician, who emphasizes a holistic and humanistic approach to patient care, partnering with his patients and their families to create a relationship that is mutual and nurturing, but foremost, based upon accuracy and clarity as to the neurological condition to be addressed.